BiotechTubeBiotechTube
Home/Shionogi/Chris Klein
CK

Chris Klein

Senior Vice President and General Counsel

Shionogi

Therapeutic Areas

Infectious DiseasesAntiviralsHIV/AIDSInfluenzaCOVID-19Fragile X SyndromeAcute Ischemic StrokeMetabolic DisordersOncologyAntibiotics

Shionogi Pipeline

DrugIndicationPhase
Investigational Oral COVID-19 AntiviralCOVID-19Clinical
Fragile X ProgramFragile X SyndromeClinical
Acute Stroke ProgramAcute Ischemic StrokeClinical
Metabolic Disorders ProgramMetabolic ConditionsClinical
Oncology ProgramCancerClinical
Novel AntibioticsBacterial InfectionsVarious
HIV TherapeuticsHIV/AIDSApproved
Influenza TreatmentsInfluenzaApproved

Leadership Team at Shionogi

NM
Nathan McCutcheon
President and Chief Executive Officer
MB
Margaret Borys
Executive Vice President and Chief Commercial Officer
TH
Tadashi Hara
Executive Vice President and Chief Global Operations Officer
DB
David Benadon
Senior Vice President, Chief Human Resources Officer
MF
Masahiro Fujita
Senior Vice President and Chief Financial Officer
View full Shionogi profile